Each year, 1 million men in the U.S. undergo biopsies to determine whether they have prostate cancer because ultrasound imaging cannot clearly display the location of tumors in the prostate gland.
Ultrasound has been used to visualize the prostate in order to take a representative sampling of tissue to biopsy but with MRI doctors can see specific lesions in the prostate and only take tissue samples from those spots.
Why aren't those two sampling methods used in combination?
A multidisciplinary team has found that biopsy guided by magnetic resonance imaging increases the rate of prostate cancer detection.